本港新增55,353宗新冠肺炎確診再創新高 再多117名患者離世
本港新增55,353宗新型冠狀病毒確診個案,再創疫情以來新高,27宗爲輸入個案,其餘55,326宗屬本地感染。第五波疫情至今已有28.1萬宗確診。
再有55間安老或殘疾院捨出現個案,包括40間安老院舍及15間殘疾院舍,涉及488名院友及228名職員。
於過去一日,有117名患者離世,包括73男44女,年齡介乎58歲至100歲,95人沒有接種疫苗,16人已接種一針,僅6人已接種兩針。另外,有64名患者危殆,88人嚴重。醫管局總行政經理(綜合臨牀服務)李立業表示,由於數據滯後,於今年2月26日至28日再有43名患者離世,第五波疫情共967名患者病逝,大部分爲長者。
衛生防護中心傳染病處首席醫生歐家榮則指,本港確診數字上升是預期之內,過去一段時間確診個案每兩至三日便倍增,目前趨勢繼續向上,相信當快速測試呈報系統推出後會有更準確數字,屆時確診病例料會進一上升。
他又稱,全民強檢期間預期會有一定限制外出措施,但目前細節仍在討論中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.